If you made any changes in Pure these will be visible here soon.

Research Output 2005 2018

  • 688 Citations
  • 11 h-Index
  • 24 Article
  • 1 Review article
Filter
Article
2018
3 Citations (Scopus)

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?

Bronte, G., Bravaccini, S., Ravaioli, S., Puccetti, M., Scarpi, E., Andreis, D., Tumedei, M. M., Sarti, S., Cecconetto, L., Pietri, E., De Simone, V., Maltoni, R., Bonafè, M., Amadori, D. & Rocca, A., Aug 1 2018, In : Translational Oncology. 11, 4, p. 950-956 7 p.

Research output: Contribution to journalArticle

Androgen Receptors
Breast Neoplasms
Neoplasm Metastasis
Neoplasms
Tumor Biomarkers
7 Citations (Scopus)

Androgen receptor in advanced breast cancer: Is it useful to predict the efficacy of anti-estrogen therapy?

Bronte, G., Rocca, A., Ravaioli, S., Puccetti, M., Tumedei, M. M., Scarpi, E., Andreis, D., Maltoni, R., Sarti, S., Cecconetto, L., Fedeli, A., Pietri, E., De Simone, V., Asioli, S., Bravaccini, S. & Amadori, D., Mar 27 2018, In : BMC Cancer. 18, 1, 348.

Research output: Contribution to journalArticle

Androgen Receptors
Estrogens
Breast Neoplasms
Progesterone Receptors
Estrogen Receptors

Phase II Study of Dehydroepiandrosterone in Androgen Receptor-Positive Metastatic Breast Cancer

Pietri, E., Massa, I., Bravaccini, S., Ravaioli, S., Tumedei, M. M., Petracci, E., Donati, C., Schirone, A., Piacentini, F., Gianni, L., Nicolini, M., Campadelli, E., Gennari, A., Saba, A., Campi, B., Valmorri, L., Andreis, D., Fabbri, F., Amadori, D. & Rocca, A., Jan 1 2018, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

Dehydroepiandrosterone
Androgen Receptors
Breast Neoplasms
Estrogen Receptors
Aromatase Inhibitors

Quantification of dehydroepiandrosterone in human serum on a routine basis: development and validation of a tandem mass spectrometry method based on a surrogate analyte

Campi, B., Frascarelli, S., Pietri, E., Massa, I., Donati, C., Bozic, R., Bertelloni, S., Paolicchi, A., Zucchi, R. & Saba, A., 2018, In : Analytical and Bioanalytical Chemistry. 410, 2, p. 407-416 10 p.

Research output: Contribution to journalArticle

2017
4 Citations (Scopus)
Ductal Carcinoma
Androgen Receptors
Estrogen Receptors
Radiotherapy
Biomarkers
5 Citations (Scopus)

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

Rocca, A., Cecconetto, L., Passardi, A., Melegari, E., Andreis, D., Monti, M., Maltoni, R., Sarti, S., Pietri, E., Schirone, A., Fabbri, F., Donati, C., Nanni, O., Fedeli, A., Faedi, M. & Amadori, D., May 1 2017, In : Cancer Chemotherapy and Pharmacology. 79, 5, p. 863-871 9 p.

Research output: Contribution to journalArticle

Toxicity
Breast Neoplasms
Diarrhea
Hand-Foot Syndrome
Anthracyclines
2015
3 Citations (Scopus)
Epirubicin
Paclitaxel
Fluorouracil
Cyclophosphamide
Breast Neoplasms
9 Citations (Scopus)

Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer

Rocca, A., Farolfi, A., Maltoni, R., Carretta, E., Melegari, E., Ferrario, C., Cecconetto, L., Sarti, S., Schirone, A., Fedeli, A., Andreis, D., Pietri, E., Ibrahim, T., Montalto, E. & Amadori, D., May 27 2015, In : Breast Cancer Research and Treatment. 152, 1, p. 57-65 9 p.

Research output: Contribution to journalArticle

Progesterone Receptors
Breast Neoplasms
Neoplasm Metastasis
Therapeutics
Neoplasms
2 Citations (Scopus)

Pharmacokinetics, pharmacodynamics and clinical efficacy of pertuzumab in breast cancer therapy

Rocca, A., Andreis, D., Fedeli, A., Maltoni, R., Sarti, S., Cecconetto, L., Pietri, E., Schirone, A., Bravaccini, S., Serra, P., Farolfi, A. & Amadori, D., Oct 3 2015, In : Expert Opinion on Drug Metabolism and Toxicology. 11, 10, p. 1647-1663 17 p.

Research output: Contribution to journalArticle

Pharmacodynamics
Pharmacokinetics
Breast Neoplasms
docetaxel
Therapeutics
45 Citations (Scopus)

Uncovering the genomic heterogeneity of multifocal breast cancer

Desmedt, C., Fumagalli, D., Pietri, E., Zoppoli, G., Brown, D., Nik-Zainal, S., Gundem, G., Rothé, F., Majjaj, S., Garuti, A., Carminati, E., Loi, S., Van Brussel, T., Boeckx, B., Maetens, M., Mudie, L., Vincent, D., Kheddoumi, N., Serra, L., Massa, I. & 9 others, Ballestrero, A., Amadori, D., Salgado, R., De Wind, A., Lambrechts, D., Piccart, M., Larsimont, D., Campbell, P. J. & Sotiriou, C., Aug 1 2015, In : Journal of Pathology. 236, 4, p. 457-466 10 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Mutation
Genome
Molecular Targeted Therapy
Neoplasms
2013
57 Citations (Scopus)

Trastuzumab-induced cardiotoxicity in early breast cancer patients: A retrospective study of possible risk and protective factors

Farolfi, A., Melegari, E., Aquilina, M., Scarpi, E., Ibrahim, T., Maltoni, R., Sarti, S., Cecconetto, L., Pietri, E., Ferrario, C., Fedeli, A., Faedi, M., Nanni, O., Frassineti, G. L., Amadori, D. & Rocca, A., May 2013, In : Heart. 99, 9, p. 634-639 6 p.

Research output: Contribution to journalArticle

Retrospective Studies
Breast Neoplasms
Epirubicin
Medical Oncology
Trastuzumab
2012
36 Citations (Scopus)

Multicentric/multifocal breast cancer with a single histotype: Is the biological characterization of all individual FOCI justified?

Buggi, F., Folli, S., Curcio, A., Casadei-Giunchi, D., Rocca, A., Pietri, E., Medri, L. & Serra, L., Aug 2012, In : Annals of Oncology. 23, 8, p. 2042-2046 5 p., mdr570.

Research output: Contribution to journalArticle

Breast Neoplasms
Neoplasm Grading
Carcinoma
Progesterone Receptors
Estrogen Receptors
2011

Case histories: Breast cancer

Gennari, A., Pietri, E. & Amadori, D., Oct 2011, In : European Journal of Cancer, Supplement. 9, 2, p. 36-42 7 p.

Research output: Contribution to journalArticle

2010
2 Citations (Scopus)
Breast Neoplasms
Anthracyclines
Maximum Tolerated Dose
Epirubicin
Febrile Neutropenia
2009
11 Citations (Scopus)
Vascular Endothelial Growth Factor A
Breast Neoplasms
Serum
Disease-Free Survival
Perioperative Period
2008
236 Citations (Scopus)

Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer

Dellapasqua, S., Bertolini, F., Bagnardi, V., Campagnoli, E., Scarano, E., Torrisi, R., Shaked, Y., Mancuso, P., Goldhirsch, A., Rocca, A., Pietri, E. & Colleoni, M., Oct 20 2008, In : Journal of Clinical Oncology. 26, 30, p. 4899-4905 7 p.

Research output: Contribution to journalArticle

Cyclophosphamide
Breast Neoplasms
Endothelial Cells
Poisons
Capecitabine
18 Citations (Scopus)
Chemotherapy
Cisplatin
Breast Neoplasms
Drug Therapy
Anthracyclines
29 Citations (Scopus)
Type II DNA Topoisomerase
Anthracyclines
Breast Neoplasms
Drug Therapy
Genes
2006
10 Citations (Scopus)
Breast Neoplasms
Drug Therapy
Fluorouracil
Epirubicin
Progesterone Receptors
6 Citations (Scopus)
11 Citations (Scopus)

Factor V Leiden mutation in patients with breast cancer with a central venous catheter: Risk of deep vein thrombosis

Curigliano, G., Mandalà, M., Sbanotto, A., Colleoni, M., Ferretti, G., Bucciarelli, P., Peruzzotti, G., De Braud, F., De Pas, T., Spitaleri, G., Pietri, E., Orsi, F., Banfi, M. G. & Goldhirsch, A., Jan 2006, In : Supportive Cancer Therapy. 3, 2, p. 98-102 5 p.

Research output: Contribution to journalArticle

Central Venous Catheters
Venous Thrombosis
Breast Neoplasms
Mutation
Prothrombin
97 Citations (Scopus)
Methotrexate
Cyclophosphamide
Breast Neoplasms
Drug Therapy
Trastuzumab
2005
49 Citations (Scopus)
Fibroblast Growth Factor 2
Transforming Growth Factor beta
Vascular Endothelial Growth Factor A
Breast Neoplasms
Mastectomy